Marc Rubin, Director at GALECTIN THERAPEUTICS INC (GALT), sold 95,370 shares at $6.00 ($574K) on 2019-02-21, disclosed to the SEC on 2019-02-25.
Open-market sale of $574k GALT by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.00 | 7,000 | $42K | 7.3% |
| 2 | $6.02 | 43,326 | $261K | 45.4% |
| 3 | $6.02 | 43,326 | $261K | 45.5% |
| 4 | $6.02 | 859 | $5K | 0.9% |
| 5 | $6.02 | 859 | $5K | 0.9% |
| Total | $6.02 avg | 95,370 |
| $574K |
| 100% |
| Filing → |
| GALT | SELL | 2018-09-06 | $78K | — | Filing → |
| GALT | SELL | 2018-09-04 | $353K | — | Filing → |
| GALT | BUY | 2017-12-08 | $13K | — | Filing → |